Novartis strikes deal with UK to provide cholesterol drug to high-risk patients – CNBC

Pharmaceutical giant Novartis has reached a deal with the U.K. government to provide its late-stage cholesterol drug, inclisiran, to patients at high risk of a heart attack, the company announced Monday.

powered by Advanced iFrame free. Get the Pro version on CodeCanyon.

Leave a Reply

Your email address will not be published. Required fields are marked *